Hirtle Callaghan & Co’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-368
Closed -$27K 168
2017
Q3
$27K Hold
368
﹤0.01% 129
2017
Q2
$24K Sell
368
-90
-20% -$5.72K ﹤0.01% 117
2017
Q1
$28K Hold
458
﹤0.01% 122
2016
Q4
$26K Sell
458
-300
-40% -$16.1K ﹤0.01% 100
2016
Q3
$36K Hold
758
0.01% 152
2016
Q2
$43K Hold
758
0.01% 122
2016
Q1
$46K Sell
758
-242
-24% -$14.1K 0.01% 134
2015
Q4
$61K Hold
1,000
0.01% 118
2015
Q3
$61K Hold
1,000
0.01% 148
2015
Q2
$61K Buy
+1,000
New +$62.8K 0.02% 152

Other funds holding CTSH

Hirtle Callaghan & Co's CTSH Position: Q4 2017 in Review

Hirtle Callaghan & Co sold out of Cognizant (CTSH) in Q4 2017, closing a stake of 368 shares — an estimated $27K sold.

Hirtle Callaghan & Co first reported a position in CTSH in Q2 2015 and held it in 10 quarters. The position peaked at $61K in Q4 2015. 1,012 funds tracked by Wall St. Rank hold CTSH as of Q4 2017.

  • Hirtle Callaghan & Co reported no remaining Cognizant position as of Q4 2017 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 368 Cognizant shares in Q4 2017, an estimated $27K.
  • Hirtle Callaghan & Co first reported a position in Cognizant in Q2 2015 and held it in 10 quarters.
  • Hirtle Callaghan & Co's Cognizant position peaked at $61K in Q4 2015.
  • 1,012 funds tracked by Wall St. Rank held Cognizant as of Q4 2017.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2017, filed 17 Jan 2018.